Provided by Tiger Trade Technology Pte. Ltd.

Precision Biosciences Inc

8.45
-0.4000-4.52%
Volume:232.78K
Turnover:2.00M
Market Cap:233.23M
PE:-3.02
High:8.82
Open:8.82
Low:8.36
Close:8.85
52wk High:9.62
52wk Low:3.53
Shares:27.60M
Float Shares:25.76M
Volume Ratio:0.67
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8007
EPS(LYR):-3.5649
ROE:-135.15%
ROA:-19.37%
PB:5.15
PE(LYR):-2.37

Loading ...

Aug 25, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 24, 2026

Major Issues Report

Form 8-K - Current report
Aug 07, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 27, 2026

Major Issues Report

Form 8-K - Current report
Jul 20, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 01, 2026

Major Issues Report

Form 8-K - Current report
Jun 16, 2026

Major Issues Report

Form 8-K - Current report
May 27, 2026

Major Issues Report

Form 8-K - Current report
May 27, 2026

Major Issues Report

Form 8-K - Current report
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Major Issues Report

Form 8-K - Current report
Apr 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Mar 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities